Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Clascoterone in Pilonidal Sinus Disease
NCT06286397Phase 2Recruiting
- Sponsor
- University of Pennsylvania
- Start
- Jan 2025
- Primary completion
- Jan 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of clascoterone in pilonidal disease, sponsored by University of Pennsylvania. Started Jan 2025; status: recruiting.
02
Drugs
clascoterone
03
Conditions
pilonidal disease
Beyond the preview
Go deeper on NCT06286397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06286397.